What is your detailed analysis of the results from ProfiLER Study evaluating NGS-based, whole exome molecular profiling in patients with advanced or refractory cancer?

What is your detailed analysis of the results from ProfiLER Study evaluating NGS-based, whole exome molecular profiling in patients with advanced or refractory cancer?

What is your detailed analysis of the results from ProfiLER Study evaluating NGS-based, whole exome molecular profiling in patients with advanced or refractory cancer?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Prof. Jean-Yves Blay, MD, PhD

Prof. Jean-Yves Blay, MD, PhD

Professor of Medicine
Université Claude Bernard
Lyon, France
Scientific Director
Canceropole Lyon Rhône Alpes